Synonyms: null
Upifitamab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. Upifitamab can be used to synthesize an ADC compound, Upifitamab rilsodotin, used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer. MW : 145.5 KD.
| Name | Citation | Sodium Channel | Others |
|---|---|---|---|
| A-803467 | 2 | ||
| Camostat Mesilate | 16 | ||
| Ambroxol HCl | 0 | ||
| Flecainide hydrochloride | 0 | ||
| Suzetrigine (VX-548) | 0 | ||
| Tenapanor | 0 | ||
| SEA0400 | 0 | ROS,ERK,p38 MAPK | |
| SLC13A5-IN-1 | 0 | ||
| LTGO-33 | 0 | ||
| EIPA (L593754) | 8 | ||
| Vernakalant (RSD1235) Hydrochloride | 0 | ||
| QX-314 chloride | 0 | ||
| VX-150 | 0 | ||
| Rimeporide | 0 | ||
| (-)-Sparteine Sulfate | 0 | ||
| Benzocaine | 0 | ||
| Tolperisone HCl | 1 | ||
| Vinpocetine | 1 |
| Description |
Upifitamab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. Upifitamab can be used to synthesize an ADC compound, Upifitamab rilsodotin, used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer. MW : 145.5 KD.
|
|---|
| CAS No. | 2254118-43-7 |
|---|---|
| Molecular Weight | 145.5 kDa |
| Isotype | Human IgG1 |
| Source | CHO |
| Purification | AKTA |
| Sterility | 0.2 μM filtered |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.